Affiliation: GlaxoSmithKline Research and Development
- Efficacy and tolerability of ropinirole in patients with restless legs syndrome and a baseline IRLS total score > or = 24 points--data from the ropinirole clinical trial programmeLuigi Giorgi
GlaxoSmithKline, Greenford, UK
Curr Med Res Opin 22:1867-77. 2006..Analyses were conducted in a subpopulation of patients with a baseline score on the International Restless Legs Scale (IRLS) of at least 24 points...